Vertex Pharmaceuticals, Inc. (VRTX)
547.74
-0.31
(-0.06%)
USD |
NASDAQ |
Aug 24, 16:00
548.20
+0.46
(+0.08%)
After-Hours: 20:00
Vertex Pharmaceuticals Market Cap : 138.77B for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 138.85B |
| August 20, 2026 | 136.87B |
| August 19, 2026 | 139.86B |
| August 18, 2026 | 133.82B |
| August 17, 2026 | 130.61B |
| August 14, 2026 | 128.13B |
| August 13, 2026 | 130.84B |
| August 12, 2026 | 133.19B |
| August 11, 2026 | 134.19B |
| August 10, 2026 | 132.73B |
| August 07, 2026 | 125.68B |
| August 06, 2026 | 122.63B |
| August 05, 2026 | 122.83B |
| August 04, 2026 | 121.28B |
| August 03, 2026 | 119.26B |
| July 31, 2026 | 120.85B |
| July 30, 2026 | 122.01B |
| July 29, 2026 | 122.43B |
| July 28, 2026 | 124.64B |
| July 27, 2026 | 121.74B |
| July 24, 2026 | 121.33B |
| July 23, 2026 | 120.24B |
| July 22, 2026 | 120.11B |
| July 21, 2026 | 122.51B |
| July 20, 2026 | 122.13B |
| Date | Value |
|---|---|
| July 17, 2026 | 123.43B |
| July 16, 2026 | 123.53B |
| July 15, 2026 | 121.26B |
| July 14, 2026 | 121.06B |
| July 13, 2026 | 122.06B |
| July 10, 2026 | 123.37B |
| July 09, 2026 | 126.19B |
| July 08, 2026 | 126.68B |
| July 07, 2026 | 132.74B |
| July 06, 2026 | 134.60B |
| July 02, 2026 | 134.21B |
| July 01, 2026 | 126.58B |
| June 30, 2026 | 126.25B |
| June 29, 2026 | 126.99B |
| June 26, 2026 | 124.88B |
| June 25, 2026 | 122.04B |
| June 24, 2026 | 120.78B |
| June 23, 2026 | 119.06B |
| June 22, 2026 | 118.64B |
| June 18, 2026 | 114.79B |
| June 17, 2026 | 116.66B |
| June 16, 2026 | 115.18B |
| June 15, 2026 | 114.49B |
| June 12, 2026 | 113.08B |
| June 11, 2026 | 113.11B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Gilead Sciences, Inc. | 182.13B |
| Alnylam Pharmaceuticals, Inc. | 31.57B |
| Regeneron Pharmaceuticals, Inc. | 85.69B |
| Sionna Therapeutics, Inc. | 252.47M |
| Biogen, Inc. | 32.21B |
Market Cap Related Metrics
| PE Ratio | 31.87 |
| PS Ratio | 11.05 |
| PEG Ratio | 1.394 |
| Price to Book Value | 6.854 |
| Price to Free Cash Flow | 36.98 |
| Price | 547.74 |
| Earnings Yield | 3.14% |
| PEGY Ratio | 1.394 |
| Operating PE Ratio | 27.96 |
| Normalized PE Ratio | 31.02 |